{
    "clinical_study": {
        "@rank": "55382", 
        "arm_group": [
            {
                "arm_group_label": "Romiplostin group"
            }, 
            {
                "arm_group_label": "Eltrombopag group"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a retrospective analysis of children (\u226421years old) who received clinical treatment\n      with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013.  The children\n      included in this study were from Weill Medical College of Cornell University, New York, NY\n      and Children's Hospital Orange County, Orange, CA"
        }, 
        "brief_title": "A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag Froom 2009-2013", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Immune Thrombocytopenia", 
        "condition_browse": {
            "mesh_term": "Thrombocytopenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. All patients in this study had received prior treatments before the start of TPO\n        treatment including corticosteroids, IVIG, IV anti-D, and/or Rituximab.\n\n        Exclusion Criteria:\n\n        1. Children who do not have ITP"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Years", 
            "minimum_age": "19 Months", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients eligible for this study included both males and females \u2264 21 years old (actual\n        range 19 months - 19 years) with persistent/chronic ITP lasting >6 months and were\n        diagnosed according to the clinical practice guidelines from the American Society of\n        Hematology."
            }
        }, 
        "enrollment": {
            "#text": "33", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974232", 
            "org_study_id": "1310014390"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "ITP,TPO agents, Children, Romiplostin and Eltrombopag", 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Weill Cornell Medical College"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag Froom 2009-2013", 
        "other_outcome": {
            "measure": "Persentage of weeks with platelet counts greater than or = to 50,000 independant of rescue therapy.", 
            "safety_issue": "No", 
            "time_frame": "For Rescue therapy is defined as receiving IVIG increased dose steroids or platelet transfusions .  When given this resulted in exclusion of platelet counts for  2 full weeks after iniciation of rescue therapy .."
        }, 
        "overall_official": {
            "affiliation": "Weill Medical College of Cornell University", 
            "last_name": "James Bussel, M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Platelet count greater than or = to 50,000", 
            "safety_issue": "No", 
            "time_frame": "on two consectutive weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974232"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "An increase in platelets greater than or = to 20,000 over baseline.", 
            "safety_issue": "No", 
            "time_frame": "On two consecutive weeks"
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "collaborator": {
                "agency": "Children\u2019s Hospital of Orange County", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}